[
  {
    "ts": null,
    "headline": "Shareholders Approve Bylaw Amendments at Regeneron Pharmaceuticals (NasdaqGS:REGN) Annual Meeting",
    "summary": "Regeneron Pharmaceuticals (NasdaqGS:REGN) recently conducted its Annual General Meeting, resulting in approved changes to its company bylaws. The amendments, along with the promising results from the EVEREST Phase 4 study, indicate strong governance and product development. Despite these developments, the company's share price remained relatively flat over the past week, aligning with the broader market's stability. While the market showed a 9.9% rise over the past year and anticipates a 15%...",
    "url": "https://finnhub.io/api/news?id=fe674798802401776925d4d293dd3da2a7a7b66a4bcef989142659cec0dfac31",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750353822,
      "headline": "Shareholders Approve Bylaw Amendments at Regeneron Pharmaceuticals (NasdaqGS:REGN) Annual Meeting",
      "id": 135414209,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Regeneron Pharmaceuticals (NasdaqGS:REGN) recently conducted its Annual General Meeting, resulting in approved changes to its company bylaws. The amendments, along with the promising results from the EVEREST Phase 4 study, indicate strong governance and product development. Despite these developments, the company's share price remained relatively flat over the past week, aligning with the broader market's stability. While the market showed a 9.9% rise over the past year and anticipates a 15%...",
      "url": "https://finnhub.io/api/news?id=fe674798802401776925d4d293dd3da2a7a7b66a4bcef989142659cec0dfac31"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals, Inc. (REGN) Growth Story Shifts as Wells Fargo Maintains Hold",
    "summary": "On June 10, 2025, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) received a ‘Hold’ rating from Wells Fargo, which set the company’s stock price target at $580. REGN is one of the 7 52-week low dividend stocks to consider Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), a biotechnology company, develops treatments in ophthalmology, oncology, and immunology. Wells Fargo’s analyst, Mohit Bansal, […]",
    "url": "https://finnhub.io/api/news?id=5168b0db161c01e3afbf0b0ae5f64e9415fda74343777c76acb233b63b480ada",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750314175,
      "headline": "Regeneron Pharmaceuticals, Inc. (REGN) Growth Story Shifts as Wells Fargo Maintains Hold",
      "id": 135387185,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "On June 10, 2025, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) received a ‘Hold’ rating from Wells Fargo, which set the company’s stock price target at $580. REGN is one of the 7 52-week low dividend stocks to consider Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), a biotechnology company, develops treatments in ophthalmology, oncology, and immunology. Wells Fargo’s analyst, Mohit Bansal, […]",
      "url": "https://finnhub.io/api/news?id=5168b0db161c01e3afbf0b0ae5f64e9415fda74343777c76acb233b63b480ada"
    }
  },
  {
    "ts": null,
    "headline": "Celltrion opens new UK headquarters in Uxbridge, UK",
    "summary": "LONDON, June 19, 2025--Celltrion UK has officially opened its new UK headquarters at the Charter Building in Uxbridge, UK, reinforcing the company’s dedication to long-term growth and partnership in the UK market.",
    "url": "https://finnhub.io/api/news?id=d1f6e939eca9d2a8bd2e36883073c0a9d9da3c9d1a11a02bb608cac50a78f4ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750301340,
      "headline": "Celltrion opens new UK headquarters in Uxbridge, UK",
      "id": 135376358,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "LONDON, June 19, 2025--Celltrion UK has officially opened its new UK headquarters at the Charter Building in Uxbridge, UK, reinforcing the company’s dedication to long-term growth and partnership in the UK market.",
      "url": "https://finnhub.io/api/news?id=d1f6e939eca9d2a8bd2e36883073c0a9d9da3c9d1a11a02bb608cac50a78f4ed"
    }
  }
]